These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1365649)

  • 1. Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
    Roy-Byrne PP; Cowley DS; Hommer D; Greenblatt DJ; Kramer GL; Petty F
    Psychopharmacology (Berl); 1992; 109(1-2):153-6. PubMed ID: 1365649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of benzodiazepines on plasma levels of homovanillic acid in anxious patients and control subjects.
    Wingerson DK; Cowley DS; Kramer GL; Petty F; Roy-Byrne PP
    Psychiatry Res; 1996 Nov; 65(1):53-9. PubMed ID: 8953661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.
    Cowley DS; Roy-Byrne PP; Radant A; Ritchie JC; Greenblatt DJ; Nemeroff CB; Hommer DW
    Neuropsychopharmacology; 1995 Apr; 12(2):147-57. PubMed ID: 7779243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Klein E; Zinder O; Colin V; Zilberman I; Levy N; Greenberg A; Lenox RH
    Acta Psychiatr Scand; 1995 Dec; 92(6):399-408. PubMed ID: 8837965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Chouinard G; Labonte A; Fontaine R; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of individual differences in alprazolam self-medication.
    Oswald LM; Roache JD; Rhoades HM
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):379-90. PubMed ID: 10609973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine effects of diazepam in panic and generalized anxiety disorders.
    Roy-Byrne PP; Cowley DS; Hommer D; Ritchie J; Greenblatt D; Nemeroff C
    Biol Psychiatry; 1991 Jul; 30(1):73-80. PubMed ID: 1654136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects.
    Roy-Byrne P; Wingerson DK; Radant A; Greenblatt DJ; Cowley DS
    Am J Psychiatry; 1996 Nov; 153(11):1444-9. PubMed ID: 8890678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of gamma-aminobutyric acid and panic disorder.
    Goddard AW; Narayan M; Woods SW; Germine M; Kramer GL; Davis LL; Petty F
    Psychiatry Res; 1996 Jul; 63(2-3):223-5. PubMed ID: 8878319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin as a potential treatment for anxiety disorders.
    Pollack MH; Matthews J; Scott EL
    Am J Psychiatry; 1998 Jul; 155(7):992-3. PubMed ID: 9659873
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma interleukin-1 beta concentrations in panic disorder.
    Brambilla F; Bellodi L; Perna G; Bertani A; Panerai A; Sacerdote P
    Psychiatry Res; 1994 Nov; 54(2):135-42. PubMed ID: 7761548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.